CTRI/2021/05/033771
Recruiting
未知
Efficacy of Pulsed Inhaled Nitric OXide (iNO) in adults with asymptomatic or mildly symptomatic COVID patients without co-morbidities (EPINOX study). A single centre, academic, prospective, case control, non-randomized, open labelled, interventional, comparative study - EPINOX
Sir h n Reliance Foundation hospital and research centre0 sites0 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhereHealth Condition 2: B338- Other specified viral diseases
- Sponsor
- Sir h n Reliance Foundation hospital and research centre
- Status
- Recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Adults, 18 â?? 50 years(account for 60% of cases in India as on May 6, 2021\), with positive rtPCR and consenting to the study within 48 hours of diagnosis, already admitted or willing to get admitted to the COVID facility at SevenHills Hospital, managed by Sir H N Reliance Foundation Hospital, with asymptomatic or mildly symptomatic symptoms.
Exclusion Criteria
- •A.Comorbid factors:
- •2\.Hypertension or hypotension
- •3\.Diabetes Mellitus
- •4\.Renal injury or failure
- •5\.Known abnormal Haemoglobinopathies
- •6\.Known clinically significant Pulmonary Arterial Hypertension
- •7\.Known congenital heart disease operated or otherwise
- •8\.Heart Failure (LVF \<40%)
- •B.Other factors:
- •1\.Additional treatment with Steroids, Tocilizumab, Plasma therapy.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Effects of nitric oxide inhalation therapy in the percutaneous ventricular assist device (Impella).JPRN-UMIN000050133Iwate Medical University50
Not yet recruiting
Phase 4
Effect of nitrous oxide inhalation sedation on childs anxiety and parental opinion during dental proceduresCTRI/2024/06/068490ANIL NEERUKONDA INSTITUTE OF DENTAL SCIENCES
Active, not recruiting
Phase 1
Pulsed, inhaled nitric oxide (iNO) for the treatment of patients with mild ormoderate corona virus disease (COVID-19)EUCTR2020-002394-94-BEDr. De Backer Wilfried BV6
Active, not recruiting
Not Applicable
The Effects of Nitric Oxide for Inhalation during Left Ventricular Assist Device (LVAD)Implantation. - INOT41acute right ventricular failureMedDRA version: 9.1Level: LLTClassification code 10063082Term: Acute right ventricular failureEUCTR2005-000326-24-DEINO Therapeutics110
Active, not recruiting
Phase 1
The Effects of Nitric Oxide for Inhalation during Left Ventricular Assist Device (LVAD) Implantation. - INOT41EUCTR2005-000326-24-GBINO Therapeutics110